AI and Safety: Finding the Signals that Matter

How today’s SSO reduces site burden and spearheads clinical system interoperability.

With close collaboration between sponsors, CROs, and regulators, this emerging technology has the potential to greatly improve the lives of patients.

Examining the implications of the recent US executive orders concerning diversity, equity, and inclusion pursuits—and the key questions each clinical trial stakeholder must now navigate.

Recent actions by the FDA and NIH in response to the current political climate have left key stakeholders in clinical trials with limited resources to conduct equitable research.

The key considerations for sponsors in deciding whether to claim the credit.

Conference breakout session explores strategies for trial sites to strengthen patient relationships.